Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
Q1 2026 earnings • in 3 days
See details
BNTX:NASDAQ
BioNTech SE - ADR
97,54 US$
-5,71%
(-5,91) 1D
97,54 US$
0,00% (0,00)
After hours
Closed: 1 მაი, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNTX...
Open
98,48 US$
High
99,09 US$
Low
95,42 US$
Mkt. cap
24,67 მლრდ.
Avg. vol.
1,54 მლნ.
Volume
1,08 მლნ.
52-wk high
123,98 US$
52-wk low
79,52 US$
EPS
-5,51 US$
Beta
1,56
Shares outstanding
252,88 მლნ.
No. of employees
8 ათ.
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
2 საათის წინ
BioNTech Faces Tariff Risks And Leadership Shift As Oncology Plans Advance
MarketBeat
MarketBeat
·
19 საათის წინ
BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next?
TipRanks
TipRanks
·
1 დღის წინ
Why BioNTech Stock Is Suddenly Sinking Today
Profile
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
About BioNTech SE - ADR
CEOუღურ შაჰინი
Employees7,81 ათ.
Founded2008
Headquarters-
Sector-
Websitebiontech.de
Next call 3 დღეში
სამ, 5 მაი, 08:00
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-1,92 est.)EUR
Revenue / Estimate
-/ (155,38 მლნ. est.)EUR
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
მარ. 2025
ივნ. 2025
სექ. 2025
დეკ. 2025
Revenue
182,80 მლნ.
260,80 მლნ.
1,52 მლრდ.
907,40 მლნ.
Cost of goods sold
83,80 მლნ.
76,40 მლნ.
148,30 მლნ.
302,80 მლნ.
Cost of revenue
83,80 მლნ.
76,40 მლნ.
148,30 მლნ.
302,80 მლნ.
Research and development expenses
525,60 მლნ.
509,10 მლნ.
564,80 მლნ.
505,40 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
120,60 მლნ.
137,40 მლნ.
148,50 მლნ.
217,90 მლნ.
Operating expense
593,40 მლნ.
621,10 მლნ.
1,40 მლრდ.
907,20 მლნ.
Total operating expenses
677,20 მლნ.
697,50 მლნ.
1,55 მლრდ.
1,21 მლრდ.
Operating income
-494,40 მლნ.
-436,70 მლნ.
-33,00 მლნ.
-302,60 მლნ.
Other non operating income
122,60 მლნ.
105,40 მლნ.
96,80 მლნ.
-173,80 მლნ.
EBT including unusual items
-445,40 მლნ.
-402,70 მლნ.
24,70 მლნ.
-227,40 მლნ.
EBT excluding unusual items
-419,50 მლნ.
-379,30 მლნ.
40,70 მლნ.
-206,50 მლნ.
Income tax expense
-29,60 მლნ.
-16,10 მლნ.
53,40 მლნ.
77,60 მლნ.
Effective tax rate
6,65%
4,00%
216,19%
-34,12%
Other operating expenses
-52,80 მლნ.
-25,40 მლნ.
690,30 მლნ.
183,90 მლნ.
Net income
-415,80 მლნ.
-386,60 მლნ.
-28,70 მლნ.
-305,00 მლნ.
Net profit margin
-227,46%
-148,24%
-1,89%
-33,61%
Earnings per share
-1,73
-1,60
-0,12
-0,33
Interest and investment income
-
-
-
265,50 მლნ.
Interest expense
-7,90 მლნ.
-6,60 მლნ.
-2,60 მლნ.
-
Net interest expenses
-7,90 მლნ.
-6,60 მლნ.
-2,60 მლნ.
265,50 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-451,60 მლნ.
-385,70 მლნ.
91,20 მლნ.
-266,95 მლნ.
Gain or loss from assets sale
-100,00 ათ.
-300,00 ათ.
-1,30 მლნ.
-800,00 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer